SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy is a research paper published in Annals of Internal Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01 AR080659
National Institutes of Health
Grant: U19 AI110818
National Institutes of Health
Grant: P30 AI060354
NHLBI NIH HHS
Grant: K24 HL166024
NIAMS NIH HHS
Grant: P30 AR070253
NIAID NIH HHS
Grant: R01 AI176287
NIAID NIH HHS
Grant: T32 AI007387
National Institutes of Health
Grant: 5R01AI176287-03
Characterization of Persistent COVID-19
National Institutes of Health
Grant: 2U19AI110818-06
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
National Institutes of Health
Grant: 5K24HL166024-02
Mentoring patient-oriented research to improve cardiovascular health among people with HIV in sub-Saharan Africa
National Institutes of Health
Grant: 5R01AR080659-02
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
National Institutes of Health
Grant: 1P30AI060354-01
Harvard Medical School Center for AIDS Research
Massachusetts Consortium on Pathogen Readiness
Gordon and Llura Gund Foundation
Fields of Study
MeSH Terms
Keywords